Newly-released Pulse Electromagnetic Field Therapy Devices Market industry analysis report by Future Market Insights shows that global sales of the Pulse Electromagnetic Field Therapy Devices Market in 2021 were held at USD 416.6 million. With 8.6%, the projected market growth from 2022 to 2032 is expected to be higher than the historical growth. The market through the Low-Frequency segment is expected to gross the highest revenue, accounting for a CAGR of nearly 8.8% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Pulse Electromagnetic Field Therapy Devices Market (2022) | USD 452.4 million |
| Global Pulse Electromagnetic Field Therapy Devices Market (2032) | USD 1 billion |
| Global Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032) | 8.6% |
| USA Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032) | 8% |
| Key Companies Profiled | Bedfont Scientific; Orthofix Holdings; Nuage Health; Bemer; Oxford Medical Instruments Health; OSKA; Medithera; NiuDeSai; I-Tech Medical Division |
Explore FMI!
Book a free demo
As per the Pulse Electromagnetic Field Therapy Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pulse Electromagnetic Field Therapy Devices Market industry increased at around 7.8% CAGR. Countries such as the USA, United Kingdom, China, Japan, and, South Korea held a significant share of the global market.
PEMF (pulsed electromagnetic field) therapy devices are non-invasive and have no known negative effects. PEMF therapy is a treatment option for a variety of musculoskeletal problems. The FDA has approved PEMF devices for the treatment of non-union fractures as well as post-operative osteoarthritis, plantar fasciitis, discomfort, and edema.
These devices also have a number of advantages, including the reduction of chronic and acute pain associated with a variety of connective tissues, such as bone, tendon, ligament, and cartilage injury, as well as the control of edema and inflammation. As a result, the advantages of these devices are expected to drive market expansion.
The market is expected to rise due to an increase in the global elderly population and increased awareness of pulse electromagnetic field (PEMF) therapy devices. The market position is projected to be secured by technological improvements including the development of narrow, downsized PEMF therapeutic devices employing sophisticated materials. The addition of telemedicine is likely to broaden the range of applications for these devices.
Severe spinal injuries, as well as delayed union and non-union fractures, are the most common outcomes of road accidents and trauma, necessitating surgical intervention. During the treatment of failed spinal fusions, delayed unions, fracture non-union, and new fractures, PEMF therapy devices stimulate bone repair.
The International Osteoporosis Foundation estimates that osteoporosis causes 8.9 million fractures per year. Furthermore, approximately 1.6 million hip fractures occur globally each year, with this figure expected to rise to between 4.5 and 6.3 million by 2050. As a result, the demand for PEMF therapy devices is likely to rise as the number of instances of osteoporosis rises.
The surge in the number of fractures due to falls, accidents, and sports injuries and Poor conditions of roads in various countries are some of the factors responsible for the growth of the market. Fractures caused by sports injuries, accidents, falls from a certain height, and symptoms such as arthritis, knee discomfort, and joint pain affect a major section of people around the world.
According to WHO figures, around 1.3 million people die each year as a result of traffic accidents. Furthermore, low- and middle-income countries account for the majority of worldwide traffic fatalities. Poorly maintained roads can result in a variety of injuries and pain in various body areas.
Potholes, uneven roads, broken surfaces, and road cracking can all cause injury to pedestrians, necessitating medical attention. Furthermore, governments' lack of focus on improving road infrastructure raises the risk of accidents and other injuries that can cause significant pain, raising healthcare expenses for individuals.
Interventional Orthopaedics of Atlanta is promoting PEMF therapy, an orthopedic clinic in Atlanta, Georgia, for the treatment of chronic tiredness symptoms, osteoporosis, and poor wound healing. The market for pulse electromagnetic field therapy devices in the United States is growing as a result of these discoveries.
PEMF technology is known for generating energy in the body's cells without requiring invasive surgery. For enterprises in the pulse electromagnetic field (PEMF) therapeutic equipment industry, such advantages translate into value-grab opportunities. PEMF therapy boosts the body's natural function by amplifying the body's natural energy. This therapy aids in the improvement of sports performance as well as the speedier recovery of injuries.
Because electromagnetic therapies cause a wide range of interactions within the body, some patients have reported discomfort during their first sessions. As a result, these occurrences occur seldom during the initial stages of treatment. Mild side effects are more common with whole-body treatments and, in rare situations, local therapies.
PEMF side effects are small and transitory, and they normally go away after the therapy is continued. Furthermore, people with electromagnetic hypersensitivity are more likely to have these side effects. Patients may experience overreactions because PEMF therapy has the power to modify biological systems and excite cells or tissues.
United States remains the most dominant country in the Pulse Electromagnetic Field Therapy Market having the expected largest market share of USD 358.3 million by 2032. The demand for PEMF therapy devices in the United States is expected to rise as the number of individuals suffering from osteoporosis and osteoarthritis rises. Furthermore, the growing shift to minimally invasive procedures is expected to boost regional growth. In addition, the presence of a well-developed healthcare system in the United States is expected to stimulate the demand.
The market in the United Kingdom is projected to reach a valuation of USD 48 million by 2032. With a CAGR of 9.8% from 2022 to 2032, the market is expected to gross an absolute dollar opportunity of USD 29 million during the forecast period.
In Japan, the market is expected to reach USD 46 million by 2032. The market in the country is projected to gross an absolute dollar opportunity of USD 31 million during the forecast period, growing at a CAGR of 11.6%.
The market in South Korea is projected to witness an absolute dollar opportunity of USD 9.6 million during the forecast period. By 2032, the market in the country is likely to reach USD 17 million by 2032, growing at a CAGR of 8.5%.
The Low-Frequency pulsed electromagnetic field therapy devices market is expected to account for the highest CAGR of 8.8%. Low-frequency PEMF devices generate magnetic fields with frequencies that are medium-high but low in intensity. These devices may also be used to address hard tissues and delayed bone growth. Low-frequency PEMF devices are used to treat rheumatoid arthritis inflammation, pain, and impairments in a quick, non-invasive, and simple way. As a result, the use of low-frequency PEMF therapy devices for arthritis treatment is likely to drive growth.
Some of the players operating in the pulse electromagnetic field therapy devices market include Bedfont Scientific, Orthofix Holdings, Nuage Health, Bemer, Oxford Medical Instruments Health, OSKA, Medithera, NiuDeSai, and I-Tech Medical Division.
Some of the recent developments of key players in the Pulse Electromagnetic Field Therapy Devices Market are as follows:
Similarly, recent developments related to companies offering Pulse Electromagnetic Field Therapy Devices Market have been tracked by the team at Future Market Insights, which is available in the full report.
The global Pulse Electromagnetic Field Therapy Devices Market is worth more than USD 416.6 Million at present.
The value of the Pulse Electromagnetic Field Therapy Devices Market is projected to increase at a CAGR of around 8.6% during 2022 to 2032.
The value of the Pulse Electromagnetic Field Therapy Devices Market increased at a CAGR of around 7.8% from 2017 to 2021.
With a CAGR of 8.3% historically, Low-Frequency segment dominated the Pulse Electromagnetic Field Therapy Devices industry.
The top 5 countries driving demand for Pulse Electromagnetic Field Therapy Devices Market are the USA, the United Kingdom., China, Japan, and South Korea.
The Japanese market for Pulse Electromagnetic Field Therapy Devices is projected to expand at a CAGR of around 11.6% during 2022 to 2032.
While the market in South Korea is expected to grow at nearly 8.5%, the market in the United Kingdom is projected to register a CAGR of nearly 9.8% from 2022 to 2032.
Protein Diagnostics Market Share, Size and Forecast 2025 to 2035
CGRP Inhibitors Market Trends - Growth, Demand & Forecast 2025 to 2035
Indolent Systemic Mastocytosis treatment Market Insights: Size, Trends & Forecast 2025 to 2035
Intraoperative Fluorescence Imaging Market Report - Demand, Trends & Industry Forecast 2025 to 2035
Lung Cancer PCR Panel Market Trends, Growth, Demand & Forecast 2025 to 2035
Polymyxin Resistance Testing Market Trends – Innovations & Growth 2025 to 2035
Pulse Electromagnetic Field Therapy Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
